
As healthcare costs continue to rise, accurate cost-effectiveness estimates are crucial. However, estimating the costs and outcomes of different interventions is complicated by uncertainty.
In model-based health economic evaluations (HEEs), uncertainty can arise from limited data, methodological limitations, and variability in clinical outcomes.
A recent review identified 80 methods for identifying, analyzing, and communicating uncertainty in HEEs. Quantifying uncertainty wherever possible is crucial to ensure accurate and unbiased cost-effectiveness estimates, ultimately leading to optimal allocation of healthcare resources
Recent Posts
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Efficiency
UK Clinical Trial Reforms Slash Approval Times
UK Clinical Trial Reforms have accelerated clinical trial approvals, reducing average times from 91 days to 41 days through risk-proportionate changes at the Medicines and Healthcare produ...
AI in South African Healthcare: Professionals’ Confidence in Reducing Admissions and Enhanc...
AI Optimism in South Africa's Healthcare Landscape
AI in South African Healthcare is gaining momentum, as evidenced by the Philips Future Health Index (FHI...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Healthcare Sector
Escaping Fee-for-Service: Pathways to Sustainable Reimbursement Models
The Council for Medical Schemes (CMS) Annual Report 2024/25 undersc...